A Practical Approach to Pharmaceutical Policy
This book discusses the wide range of challenges faced by policy makers in the pharmaceutical sector, presents the current know-how in terms of policy measures, and provides specific examples of policy packages that can be used in defined circumsta...
| Main Author: | |
|---|---|
| Format: | Publication |
| Language: | English |
| Published: |
World Bank
2012
|
| Subjects: | |
| Online Access: | http://www-wds.worldbank.org/external/default/main?menuPK=64187510&pagePK=64193027&piPK=64187937&theSitePK=523679&menuPK=64187510&searchMenuPK=64187283&siteName=WDS&entityID=000334955_20100622050742 http://hdl.handle.net/10986/2468 |
| id |
okr-10986-2468 |
|---|---|
| recordtype |
oai_dc |
| repository_type |
Digital Repository |
| institution_category |
Foreign Institution |
| institution |
Digital Repositories |
| building |
World Bank Open Knowledge Repository |
| collection |
World Bank |
| language |
English |
| topic |
ABUSE ACCOUNTABILITY ACQUIRED IMMUNODEFICIENCY SYNDROME BIOLOGICALS BRAND BRIBERY BUDGETING CANCER CAPSULES CARDIOVASCULAR DISEASE CENTRAL MEDICAL STORES CHEMISTS CHILD MORTALITY CHRONIC DISEASES CIF CITIZENS CITIZENSHIP CIVIL SOCIETY ORGANIZATIONS CLINICAL TRIALS CLINICS COMMODITIES COMPETITIVE BIDDING COMPETITIVENESS COMPLICATIONS CONSUMER GROUPS CORRUPTION DEATH RATES DECISION MAKING DELIVERY SYSTEMS DEMOCRACY DEVELOPING COUNTRIES DEVELOPMENT GOALS DEVELOPMENT POLICY DIABETES DISABILITY DISCRIMINATION DISSEMINATION DISTRIBUTION SYSTEMS DOMESTIC MANUFACTURERS DONOR FINANCING DOSAGE FORMS DRUG CONTROL DRUG DONATIONS DRUG INDUSTRY DRUG PRICES DRUGS ECONOMIC GROWTH EDUCATION SYSTEMS EMERGING MARKETS ENVIRONMENTAL PROTECTION ESSENTIAL DRUGS ESSENTIAL MEDICINES FAMILIES FAMILY MEMBERS FAVORITISM FIXED COSTS FRAUD FUTURE GROWTH GENERIC DRUGS GLOBAL DEVELOPMENT GLOBAL POLICY GMP GOOD GOVERNANCE GOOD MANUFACTURING PRACTICES GOVERNMENT AGENCIES HEALTH CARE HEALTH CARE ACCESS HEALTH CARE PROVIDERS HEALTH CARE REFORM HEALTH CARE SYSTEM HEALTH CENTERS HEALTH FACILITIES HEALTH INSURANCE HEALTH MANAGEMENT HEALTH OUTCOMES HEALTH POLICIES HEALTH POLICY HEALTH REFORM HEALTH SECTOR HEALTH SERVICES HEALTH SYSTEM HEALTH SYSTEMS HEALTH WORKERS HIGH BLOOD PRESSURE HIV HOME COUNTRIES HOSPITAL HOSPITALS HUMAN DEVELOPMENT HUMAN IMMUNODEFICIENCY VIRUS ILLNESS ILLNESSES IMMUNIZATION IMMUNODEFICIENCY IMPORTED DRUGS INDUSTRIAL DEVELOPMENT INDUSTRIAL PRODUCTION INFORMATION SYSTEMS INTERMEDIARIES INTERNATIONAL AGREEMENTS INTERNATIONAL ORGANIZATIONS INVENTORY INVENTORY MANAGEMENT LABORATORIES LAWS LEGAL STATUS LIFE EXPECTANCY LOCAL ECONOMY LOCAL MANUFACTURERS LOW-INCOME COUNTRIES LOW-INCOME COUNTRY MALARIA MANAGEMENT SYSTEMS MARKET ENTRY MARKETING MEDICAL EDUCATION MEDICAL NEEDS MEDICAL SCHOOL MEDICAL SERVICES MEDICAL SPECIALISTS MEDICAL SUPPLIES MEDICINE MEDICINES MILLENNIUM DEVELOPMENT GOALS MINISTRIES OF HEALTH MINISTRY OF HEALTH MORTALITY NARCOTICS NATIONAL DRUG NATIONAL GOVERNMENT NATIONAL LEGISLATION NURSE NURSES NUTRITION OPERATING COSTS PACKAGING PATIENT PATIENTS PAYMENT TERMS PERSONAL RELATIONSHIPS PHARMACEUTICAL PHARMACEUTICAL COMPANIES PHARMACEUTICAL EXPENDITURE PHARMACEUTICAL INDUSTRY PHARMACEUTICAL MANUFACTURERS PHARMACEUTICAL MARKETING PHARMACEUTICAL MARKETS PHARMACEUTICAL POLICIES PHARMACEUTICAL POLICY PHARMACEUTICAL PRICING PHARMACEUTICAL PRICING POLICIES PHARMACEUTICAL PROCUREMENT PHARMACEUTICAL PRODUCTS PHARMACEUTICAL REFORM PHARMACEUTICAL REGULATION PHARMACEUTICAL SECTOR PHARMACEUTICAL SUPPLY PHARMACEUTICAL ¸ MANUFACTURERS PHARMACEUTICALS PHARMACIES PHARMACISTS PHARMACOLOGISTS PHARMACY PHYSICIANS POLICY DECISIONS POLICY FRAMEWORK POLICY GOALS POLICY MAKERS POLITICAL CHANGE POLITICAL DECISION POLITICAL OPPOSITION POLITICAL SUPPORT POOLED PROCUREMENT PRACTITIONERS PRESCRIPTIONS PRICE REGULATION PRIVATE PHARMACIES PROCUREMENT PROGRESS PUBLIC HEALTH PUBLIC HEALTH POLICY PUBLIC POLICY PUBLIC SUPPORT PURCHASING PURCHASING POWER QUALITY ASSURANCE QUALITY CONTROL QUALITY OF CARE QUANTITATIVE DATA RATIONAL USE OF DRUGS REFORM EFFORT REGULATORY AGENCIES REGULATORY AUTHORITIES REGULATORY BARRIERS RESPECT RETAIL RETAIL PHARMACIES RISK FACTORS RURAL AREAS SALES SECURE SUPPLY SERVICE DELIVERY SERVICE PROVIDERS SERVICE QUALITY SOCIAL SECURITY STOCKS SUPPLIER SUPPLIERS SUPPLY CHAIN SUPPLY CHAINS TABLETS TECHNICAL CAPACITY TRADE ISSUES TRANSPORTATION TUBERCULOSIS TURNOVER UNEMPLOYMENT UNEMPLOYMENT RATES UNIVERSAL ACCESS URBAN POPULATION USE OF RESOURCES VACCINES WAREHOUSE WAREHOUSES WHOLESALERS WORKERS WORLD HEALTH ORGANIZATION |
| spellingShingle |
ABUSE ACCOUNTABILITY ACQUIRED IMMUNODEFICIENCY SYNDROME BIOLOGICALS BRAND BRIBERY BUDGETING CANCER CAPSULES CARDIOVASCULAR DISEASE CENTRAL MEDICAL STORES CHEMISTS CHILD MORTALITY CHRONIC DISEASES CIF CITIZENS CITIZENSHIP CIVIL SOCIETY ORGANIZATIONS CLINICAL TRIALS CLINICS COMMODITIES COMPETITIVE BIDDING COMPETITIVENESS COMPLICATIONS CONSUMER GROUPS CORRUPTION DEATH RATES DECISION MAKING DELIVERY SYSTEMS DEMOCRACY DEVELOPING COUNTRIES DEVELOPMENT GOALS DEVELOPMENT POLICY DIABETES DISABILITY DISCRIMINATION DISSEMINATION DISTRIBUTION SYSTEMS DOMESTIC MANUFACTURERS DONOR FINANCING DOSAGE FORMS DRUG CONTROL DRUG DONATIONS DRUG INDUSTRY DRUG PRICES DRUGS ECONOMIC GROWTH EDUCATION SYSTEMS EMERGING MARKETS ENVIRONMENTAL PROTECTION ESSENTIAL DRUGS ESSENTIAL MEDICINES FAMILIES FAMILY MEMBERS FAVORITISM FIXED COSTS FRAUD FUTURE GROWTH GENERIC DRUGS GLOBAL DEVELOPMENT GLOBAL POLICY GMP GOOD GOVERNANCE GOOD MANUFACTURING PRACTICES GOVERNMENT AGENCIES HEALTH CARE HEALTH CARE ACCESS HEALTH CARE PROVIDERS HEALTH CARE REFORM HEALTH CARE SYSTEM HEALTH CENTERS HEALTH FACILITIES HEALTH INSURANCE HEALTH MANAGEMENT HEALTH OUTCOMES HEALTH POLICIES HEALTH POLICY HEALTH REFORM HEALTH SECTOR HEALTH SERVICES HEALTH SYSTEM HEALTH SYSTEMS HEALTH WORKERS HIGH BLOOD PRESSURE HIV HOME COUNTRIES HOSPITAL HOSPITALS HUMAN DEVELOPMENT HUMAN IMMUNODEFICIENCY VIRUS ILLNESS ILLNESSES IMMUNIZATION IMMUNODEFICIENCY IMPORTED DRUGS INDUSTRIAL DEVELOPMENT INDUSTRIAL PRODUCTION INFORMATION SYSTEMS INTERMEDIARIES INTERNATIONAL AGREEMENTS INTERNATIONAL ORGANIZATIONS INVENTORY INVENTORY MANAGEMENT LABORATORIES LAWS LEGAL STATUS LIFE EXPECTANCY LOCAL ECONOMY LOCAL MANUFACTURERS LOW-INCOME COUNTRIES LOW-INCOME COUNTRY MALARIA MANAGEMENT SYSTEMS MARKET ENTRY MARKETING MEDICAL EDUCATION MEDICAL NEEDS MEDICAL SCHOOL MEDICAL SERVICES MEDICAL SPECIALISTS MEDICAL SUPPLIES MEDICINE MEDICINES MILLENNIUM DEVELOPMENT GOALS MINISTRIES OF HEALTH MINISTRY OF HEALTH MORTALITY NARCOTICS NATIONAL DRUG NATIONAL GOVERNMENT NATIONAL LEGISLATION NURSE NURSES NUTRITION OPERATING COSTS PACKAGING PATIENT PATIENTS PAYMENT TERMS PERSONAL RELATIONSHIPS PHARMACEUTICAL PHARMACEUTICAL COMPANIES PHARMACEUTICAL EXPENDITURE PHARMACEUTICAL INDUSTRY PHARMACEUTICAL MANUFACTURERS PHARMACEUTICAL MARKETING PHARMACEUTICAL MARKETS PHARMACEUTICAL POLICIES PHARMACEUTICAL POLICY PHARMACEUTICAL PRICING PHARMACEUTICAL PRICING POLICIES PHARMACEUTICAL PROCUREMENT PHARMACEUTICAL PRODUCTS PHARMACEUTICAL REFORM PHARMACEUTICAL REGULATION PHARMACEUTICAL SECTOR PHARMACEUTICAL SUPPLY PHARMACEUTICAL ¸ MANUFACTURERS PHARMACEUTICALS PHARMACIES PHARMACISTS PHARMACOLOGISTS PHARMACY PHYSICIANS POLICY DECISIONS POLICY FRAMEWORK POLICY GOALS POLICY MAKERS POLITICAL CHANGE POLITICAL DECISION POLITICAL OPPOSITION POLITICAL SUPPORT POOLED PROCUREMENT PRACTITIONERS PRESCRIPTIONS PRICE REGULATION PRIVATE PHARMACIES PROCUREMENT PROGRESS PUBLIC HEALTH PUBLIC HEALTH POLICY PUBLIC POLICY PUBLIC SUPPORT PURCHASING PURCHASING POWER QUALITY ASSURANCE QUALITY CONTROL QUALITY OF CARE QUANTITATIVE DATA RATIONAL USE OF DRUGS REFORM EFFORT REGULATORY AGENCIES REGULATORY AUTHORITIES REGULATORY BARRIERS RESPECT RETAIL RETAIL PHARMACIES RISK FACTORS RURAL AREAS SALES SECURE SUPPLY SERVICE DELIVERY SERVICE PROVIDERS SERVICE QUALITY SOCIAL SECURITY STOCKS SUPPLIER SUPPLIERS SUPPLY CHAIN SUPPLY CHAINS TABLETS TECHNICAL CAPACITY TRADE ISSUES TRANSPORTATION TUBERCULOSIS TURNOVER UNEMPLOYMENT UNEMPLOYMENT RATES UNIVERSAL ACCESS URBAN POPULATION USE OF RESOURCES VACCINES WAREHOUSE WAREHOUSES WHOLESALERS WORKERS WORLD HEALTH ORGANIZATION Seiter, Andreas A Practical Approach to Pharmaceutical Policy |
| relation |
Directions in development ; human development |
| description |
This book discusses the wide range of
challenges faced by policy makers in the pharmaceutical
sector, presents the current know-how in terms of policy
measures, and provides specific examples of policy packages
that can be used in defined circumstances, even if one
assumes a certain degree of political resistance and
capacity limits on the side of the implementing agency. This
book focuses on developing countries and tries to address
the issues faced by both low- and middle-income countries.
The book does not cover the vaccines market and its
respective policies because too many differences exist
between the markets for vaccines and pharmaceuticals to
cover both subsectors in one publication of this type. The
book ends with an outlook on how things might evolve in the
longer term. It assumes that some form of convergence will
take place toward "models that work," thus
reducing the fragmentation of policies and enhancing
regulatory and economic efficiencies over time-one hopes to
the benefit of all stakeholders in the sector and, in
particular, those who, as patients, currently do not have
reliable access to effective and safe medicines. |
| format |
Publications & Research :: Publication |
| author |
Seiter, Andreas |
| author_facet |
Seiter, Andreas |
| author_sort |
Seiter, Andreas |
| title |
A Practical Approach to
Pharmaceutical Policy |
| title_short |
A Practical Approach to
Pharmaceutical Policy |
| title_full |
A Practical Approach to
Pharmaceutical Policy |
| title_fullStr |
A Practical Approach to
Pharmaceutical Policy |
| title_full_unstemmed |
A Practical Approach to
Pharmaceutical Policy |
| title_sort |
practical approach to
pharmaceutical policy |
| publisher |
World Bank |
| publishDate |
2012 |
| url |
http://www-wds.worldbank.org/external/default/main?menuPK=64187510&pagePK=64193027&piPK=64187937&theSitePK=523679&menuPK=64187510&searchMenuPK=64187283&siteName=WDS&entityID=000334955_20100622050742 http://hdl.handle.net/10986/2468 |
| _version_ |
1764385507549118464 |
| spelling |
okr-10986-24682021-04-23T14:02:02Z A Practical Approach to Pharmaceutical Policy Seiter, Andreas ABUSE ACCOUNTABILITY ACQUIRED IMMUNODEFICIENCY SYNDROME BIOLOGICALS BRAND BRIBERY BUDGETING CANCER CAPSULES CARDIOVASCULAR DISEASE CENTRAL MEDICAL STORES CHEMISTS CHILD MORTALITY CHRONIC DISEASES CIF CITIZENS CITIZENSHIP CIVIL SOCIETY ORGANIZATIONS CLINICAL TRIALS CLINICS COMMODITIES COMPETITIVE BIDDING COMPETITIVENESS COMPLICATIONS CONSUMER GROUPS CORRUPTION DEATH RATES DECISION MAKING DELIVERY SYSTEMS DEMOCRACY DEVELOPING COUNTRIES DEVELOPMENT GOALS DEVELOPMENT POLICY DIABETES DISABILITY DISCRIMINATION DISSEMINATION DISTRIBUTION SYSTEMS DOMESTIC MANUFACTURERS DONOR FINANCING DOSAGE FORMS DRUG CONTROL DRUG DONATIONS DRUG INDUSTRY DRUG PRICES DRUGS ECONOMIC GROWTH EDUCATION SYSTEMS EMERGING MARKETS ENVIRONMENTAL PROTECTION ESSENTIAL DRUGS ESSENTIAL MEDICINES FAMILIES FAMILY MEMBERS FAVORITISM FIXED COSTS FRAUD FUTURE GROWTH GENERIC DRUGS GLOBAL DEVELOPMENT GLOBAL POLICY GMP GOOD GOVERNANCE GOOD MANUFACTURING PRACTICES GOVERNMENT AGENCIES HEALTH CARE HEALTH CARE ACCESS HEALTH CARE PROVIDERS HEALTH CARE REFORM HEALTH CARE SYSTEM HEALTH CENTERS HEALTH FACILITIES HEALTH INSURANCE HEALTH MANAGEMENT HEALTH OUTCOMES HEALTH POLICIES HEALTH POLICY HEALTH REFORM HEALTH SECTOR HEALTH SERVICES HEALTH SYSTEM HEALTH SYSTEMS HEALTH WORKERS HIGH BLOOD PRESSURE HIV HOME COUNTRIES HOSPITAL HOSPITALS HUMAN DEVELOPMENT HUMAN IMMUNODEFICIENCY VIRUS ILLNESS ILLNESSES IMMUNIZATION IMMUNODEFICIENCY IMPORTED DRUGS INDUSTRIAL DEVELOPMENT INDUSTRIAL PRODUCTION INFORMATION SYSTEMS INTERMEDIARIES INTERNATIONAL AGREEMENTS INTERNATIONAL ORGANIZATIONS INVENTORY INVENTORY MANAGEMENT LABORATORIES LAWS LEGAL STATUS LIFE EXPECTANCY LOCAL ECONOMY LOCAL MANUFACTURERS LOW-INCOME COUNTRIES LOW-INCOME COUNTRY MALARIA MANAGEMENT SYSTEMS MARKET ENTRY MARKETING MEDICAL EDUCATION MEDICAL NEEDS MEDICAL SCHOOL MEDICAL SERVICES MEDICAL SPECIALISTS MEDICAL SUPPLIES MEDICINE MEDICINES MILLENNIUM DEVELOPMENT GOALS MINISTRIES OF HEALTH MINISTRY OF HEALTH MORTALITY NARCOTICS NATIONAL DRUG NATIONAL GOVERNMENT NATIONAL LEGISLATION NURSE NURSES NUTRITION OPERATING COSTS PACKAGING PATIENT PATIENTS PAYMENT TERMS PERSONAL RELATIONSHIPS PHARMACEUTICAL PHARMACEUTICAL COMPANIES PHARMACEUTICAL EXPENDITURE PHARMACEUTICAL INDUSTRY PHARMACEUTICAL MANUFACTURERS PHARMACEUTICAL MARKETING PHARMACEUTICAL MARKETS PHARMACEUTICAL POLICIES PHARMACEUTICAL POLICY PHARMACEUTICAL PRICING PHARMACEUTICAL PRICING POLICIES PHARMACEUTICAL PROCUREMENT PHARMACEUTICAL PRODUCTS PHARMACEUTICAL REFORM PHARMACEUTICAL REGULATION PHARMACEUTICAL SECTOR PHARMACEUTICAL SUPPLY PHARMACEUTICAL ¸ MANUFACTURERS PHARMACEUTICALS PHARMACIES PHARMACISTS PHARMACOLOGISTS PHARMACY PHYSICIANS POLICY DECISIONS POLICY FRAMEWORK POLICY GOALS POLICY MAKERS POLITICAL CHANGE POLITICAL DECISION POLITICAL OPPOSITION POLITICAL SUPPORT POOLED PROCUREMENT PRACTITIONERS PRESCRIPTIONS PRICE REGULATION PRIVATE PHARMACIES PROCUREMENT PROGRESS PUBLIC HEALTH PUBLIC HEALTH POLICY PUBLIC POLICY PUBLIC SUPPORT PURCHASING PURCHASING POWER QUALITY ASSURANCE QUALITY CONTROL QUALITY OF CARE QUANTITATIVE DATA RATIONAL USE OF DRUGS REFORM EFFORT REGULATORY AGENCIES REGULATORY AUTHORITIES REGULATORY BARRIERS RESPECT RETAIL RETAIL PHARMACIES RISK FACTORS RURAL AREAS SALES SECURE SUPPLY SERVICE DELIVERY SERVICE PROVIDERS SERVICE QUALITY SOCIAL SECURITY STOCKS SUPPLIER SUPPLIERS SUPPLY CHAIN SUPPLY CHAINS TABLETS TECHNICAL CAPACITY TRADE ISSUES TRANSPORTATION TUBERCULOSIS TURNOVER UNEMPLOYMENT UNEMPLOYMENT RATES UNIVERSAL ACCESS URBAN POPULATION USE OF RESOURCES VACCINES WAREHOUSE WAREHOUSES WHOLESALERS WORKERS WORLD HEALTH ORGANIZATION This book discusses the wide range of challenges faced by policy makers in the pharmaceutical sector, presents the current know-how in terms of policy measures, and provides specific examples of policy packages that can be used in defined circumstances, even if one assumes a certain degree of political resistance and capacity limits on the side of the implementing agency. This book focuses on developing countries and tries to address the issues faced by both low- and middle-income countries. The book does not cover the vaccines market and its respective policies because too many differences exist between the markets for vaccines and pharmaceuticals to cover both subsectors in one publication of this type. The book ends with an outlook on how things might evolve in the longer term. It assumes that some form of convergence will take place toward "models that work," thus reducing the fragmentation of policies and enhancing regulatory and economic efficiencies over time-one hopes to the benefit of all stakeholders in the sector and, in particular, those who, as patients, currently do not have reliable access to effective and safe medicines. 2012-03-19T09:34:20Z 2012-03-19T09:34:20Z 2010 http://www-wds.worldbank.org/external/default/main?menuPK=64187510&pagePK=64193027&piPK=64187937&theSitePK=523679&menuPK=64187510&searchMenuPK=64187283&siteName=WDS&entityID=000334955_20100622050742 978-0-8213-8386-5 http://hdl.handle.net/10986/2468 English Directions in development ; human development CC BY 3.0 IGO http://creativecommons.org/licenses/by/3.0/igo World Bank World Bank Publications & Research :: Publication Publications & Research :: Publication |